We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Interview: Director Kopcha Says Supply Chain, Quality Metrics Top OPQ’s Priority List
Interview: Director Kopcha Says Supply Chain, Quality Metrics Top OPQ’s Priority List
CDER’s Office of Pharmaceutical Quality (OPQ) Director Mike Kopcha leads an office of more than 1,300 staff involved in assessing drug marketing applications. FDAnews asked him about OPQ’s challenges, priorities and goals.